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Abstract Purpose: Large infusion
of crystalloids may induce acid-base
alterations according to their strong
ion difference ([SID]). We wanted to
prove in vivo, at constant PCO2, that
if the [SID] of the infused crystalloid
is equal to baseline plasma bicarbon-
ate, the arterial pH remains
unchanged, if lower it decreases, and
if higher it increases. Methods: In
12 pigs, anesthetized and mechani-
cally ventilated at PCO2 &40 mmHg,
2.2 l of crystalloids with a [SID]
similar to (lactated Ringer’s
28.3 mEq/l), lower than (normal sal-
ine 0 mEq/l), and greater than
(rehydrating III 55 mEq/l) baseline
bicarbonate (29.22 ± 2.72 mEq/l)
were infused for 120 min in ran-
domized sequence. Four hours of
wash-out were allowed between the
infusions. Every 30 min up to minute
120 we measured blood gases, plasma
electrolytes, urinary volume, pH, and
electrolytes. Albumin, hemoglobin,
and phosphates were measured at
time 0 and 120 min. Results: Lac-
tated Ringer’s maintained arterial pH
unchanged (from 7.47 ± 0.06 to
7.47 ± 0.03) despite a plasma dilu-
tion around 12%. Normal saline
caused a reduction in pH (from
7.49 ± 0.03 to 7.42 ± 0.04) and
rehydrating III induced an increase in
pH (from 7.46 ± 0.05 to
7.49 ± 0.04). The kidney reacted to
the infusion, minimizing the acid-
base alterations, by increasing/
decreasing the urinary anion gap,
primarily by changing sodium and
chloride concentrations. Lower urine
volume after normal saline infusion
was possibly due to its greater
osmolarity and chloride concentration
as compared to the other solutions.
Conclusions: Results support the
hypothesis that at constant PCO2, pH
changes are predictable from the dif-
ference between the [SID] of the
infused solution and baseline plasma
bicarbonate concentration.
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Introduction
Fluid resuscitation with large amounts of crystalloids is
usual in critically ill patients, and normal saline is the
most widely used solution for this purpose. It has been
observed that large amounts of normal saline induce
metabolic acidosis [1–3]. According to misinterpreted
Stewart’s model [4, 5], this metabolic acidosis is due to a
reduction in the plasma strong ion difference ([SID]).
However, to fully understand the relationship among the
dilution, kind of solution, and acid-base equilibrium, all
three independent variables of Stewart’s model must be
considered together, not only [SID], but also PCO2 and
the total amount of weak acids [ATOT] [6]. Normal pH is
assured by an adequate proportion of these components,
whose individual variation may have opposite effects on
pH. As an example, a decrease in PCO2 and ATOT causes
alkalosis, while a decrease in [SID] causes acidosis.
Therefore, a correct application of Stewart’s model pro-
vides the same results as the classical bicarbonate/base
excess approach [6, 7]. However, we believe that Stew-
art’s approach has the great advantage to fully integrate
the electrolyte and the acid-base equilibrium.
Whatever crystalloid solution not containing weak
anions, before the infusion, has PCO2, [ATOT], and [SID]
values equal to zero. Crystalloids containing organic ions,
such as lactated Ringer’s, develop a positive [SID] only
after the associated organic ions (such as lactate and
acetate) are metabolized [8, 9]. Therefore, when a crys-
talloid solution is added to normal plasma (PCO2 40
mmHg, [ATOT] 17 mmol/l, SID 42 mEq/l, pH 7.4) in a
closed system, the independent variables are equally
diluted, and pH remains constant—for example, a 100%
dilution of normal plasma leads to PCO2 of nearly 20
mmHg, ATOT of 8.5 mmol/l, [SID] of 21 mEq/l, and pH of
7.4. When PCO2 increases from 20 to 40 mmHg, opening
the closed system to gases, pH decreases, with [ATOT] and
[SID] being unchanged [8]. Of course, by manipulating
also the actual [SID] of the infused solution, the pH will
change accordingly.
Provided the same mechanisms operate in vivo, we may
expect that a proper combination of PCO2, [SID], and ATOT
could manipulate the acid-base equilibrium toward acido-
sis, alkalosis, or unchanged pH. Actually, it was shown that
no acidosis developed in normal animals when the diluting
solution had a [SID] of nearly 24 mEq/l [9]. We expanded
this observation, showing in vitro that plasma pH after
crystalloid dilution at constant PCO2 depends on the rela-
tionship between infused [SID] ([SID]inf) and the baseline
plasma bicarbonate concentration (½HCO3 baseline) (see the
Online Data Supplement for the mathematical derivation).
At constant PCO2, when ½SIDinf  ½HCO3 baseline ¼ 0 no
change in pH occurs, whatever the degree of dilution.
When ½SIDinf  ½HCO3 baseline [ 0 pH increases, while it
decreases when ½SIDinf  ½HCO3 baseline\0 [7].
As these rules were identified in vitro, we aimed to
confirm them in vivo, considering the animals as a ‘‘black
box.’’ In these experiments, we describe the acid-base
equilibrium of the black box for a given input (crystalloid
infusion) and output (urine volume and electrolyte com-
position). If the rules identified in vitro apply in vivo,
changes in the acid-base equilibrium following the infu-
sion of whatever crystalloid solution in subjects
undergoing volume replacement will be easily predictable
also in clinical practice.
Materials and methods
The study was approved by the Institutional Review
Board and conducted in accordance with international
recommendations [10]. Twelve healthy female pigs
weighing 22 ± 3 kg were anesthetized and mechanically
ventilated (Engstrom Carestation, GE Healthcare) with
PEEP 5 cm H2O, tidal volume 10 ml/kg and respiratory
rate adjusted to maintain PCO2 constant throughout the
experiment by capnography. Arterial, central venous, and
bladder catheters were surgically placed [11]. Two hours
of stabilization preceded the beginning of the protocol.
Study protocol
In each pig, normal saline (Baxter spa, Roma, Italy),
lactated Ringer’s (Fresenius Kabi Italia spa, Verona,
Italy), and rehydrating III (Monico spa, Venezia/Mestre,
Italy) were infused (see Table 1 for compositions). Six
different sequences of dilution were possible, so pigs were
randomly assigned to a sequence of dilutions to assure a
Table 1 Characteristics of the crystalloid solutions
Rehydrating
III (RIII)
Lactated
Ringer’s (LR)
Normal saline
(NS)
[Na?] (mEq/l) 140.0 130.9 154.0
[Cl-] (mEq/l) 103.0 111.7 154.0
[K?] (mEq/l) 10.0 5.4 0.0
[Ca2?] (mEq/l) 5.0 3.7 0.0
[Mg2?] (mEq/l) 3.0 0.0 0.0
[Lac-] (mEq/l) 0.0 28.3 0.0
[Acetate-] (mEq/l) 47 0 0
[Citrate-] (mEq/l) 8 0 0
[SID] (mEq/l) 55.0 28.3 0.0
Osmolarity (mOsm/l) 307.0 278.0 308.0
All concentrations are expressed as mEq/l. Osmolarity is expressed
as mOsm/l
Na? sodium concentration, Cl- chloride concentration, K? potas-
sium concentration, Ca2? calcium concentration, Mg2? magnesium
concentration, Lac- lactate concentration, Acetate- acetate
concentration, Citrate- citrate concentration, SID strong ion
difference, Osmolarity declared osmolarity
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balanced distribution (see Fig. 1 in the Online Data
Supplement for study design). Each experimental set
consisted of the 2-h infusion of the assigned crystalloid
solution, in the amount of 10% of baseline body weight,
followed by a 4-h ‘wash-out’ period, with the same fluid
being infused at a rate of 3 ml/h to keep the vein open.
Thereafter, a new experimental set began or, in the case of
the last study period, the animal was killed with the
injection of a bolus of 40 mEq of potassium.
Data collection
During the 2-h study period, data were collected at baseline
and every 30 min. Thereafter, during the wash-out period,
data were recorded every 2 h (minute 240 and 360). For
each point, data on arterial blood gases, electrolytes, and
acid-base variables (ABL800, Radiometer GmbH,
Germany) were recorded. Urinary output measurement
and analysis of urinary pH (pHU) and urinary electrolytes
(sodium [Na?]U, potassium [K
?]U, chloride [Cl
-]U, and
ammonium [NH4
?]U) were performed by the urinary ana-
lyzer K.IN.G (collaboration of Orvim and Kardia, Milan,
Italy) [12] and synchronized with blood data collection.
For each dilution, samples for measurement of hemoglo-
bin, albumin, and phosphates concentrations were sent to
the central laboratory at time 0, 120, 240 and 360 min.
Definitions
Fluid balance was computed as
P
Infused fluidP
Urinary output. Hemoglobin-derived (DFHb) and
albumin-derived dilution (DFAlb) were computed as pre-
viously described [13] and used to estimate plasma
dilution. The plasma [SID] and urinary anion gap [AG]U
were computed using standard formulas. The concentra-
tion of dissociated weak acids [A-] was calculated from
plasma albumin and phosphates concentration as previ-
ously described [14], and the corresponding [ATOT] was
computed rearranging the dissociation equation for weak
acids. Effective plasma osmolarity was calculated with the
standard formula from sodium and glucose (see the Online
Data Supplement for further details and equations).
Statistical analysis
Data are presented as mean ± standard deviation. Two-
way ANOVA RM was used to test the effects of different
crystalloids and time and Bonferroni’s t test for multiple
comparison. A rank transformation was used in the case
of variables that were not normally distributed and did not
pass the equal variance test. Infusion and wash-out (plus
baseline) were tested separately. Linear regression was
used to assess the level of agreement between variables.
Paired t test was used to compare DFHb and DFAlb. Sta-
tistical significance was defined as p \ 0.05. Analysis was
performed with SAS v.9.2. (SAS, Cary, NC) and Sig-
maPlot v.11.2 (Systat Software Inc., San Jose, CA).
Results
Baseline characteristics
Baseline acid-base variables and electrolytes in plasma
and urine are summarized in Table 2. Of note, before any
intervention all pigs presented slight metabolic alkalosis
and hypoalbuminemia. However, all values are consistent
with previously reported data on acid-base variables in
healthy piglets weighing between 20 and 25 kg, which,
compared to humans, present higher pH (7.48 ± 0.038),
similar PCO2 (40 ± 2.8 mmHg), higher bicarbonate
concentrations (29 ± 2.2 mEq/l), and lower albumin
concentrations (25.4 ± 2.08 g/l) [15].
Effective dilution
Table 3 summarizes the principal data concerning infused
fluids, urinary output, water balance, and consequent
Table 2 Baseline plasma and urinary acid-base variables
PCO2 (mmHg) 40.4 ± 2.7
[SID] (mEq/l) 40.43 ± 2.14
[ATOT] (mmol/l) 13.75 ± 1.73
[Alb] (g/l) 23.4 ± 4
[Phosph] (mmol/l) 2.67 ± 0.36
[BE] (mmol/l) 5.47 ± 2.78
pHa 7.47 ± 0.04
[HCO3
-] (mmol/l) 29.22 ± 2.72
[Na?] (mEq/l) 138 ± 2.73
[Cl-] (mEq/l) 103.08 ± 3.32
[K?] (mEq/l) 3.78 ± 0.34
[Ca2?] (mEq/l) 2.60 ± 0.22
[Lac-] (mEq/l) 0.88 ± 0.25
Osmolarity (mOsm/l) 281.1 ± 5.1
pHU 6.49 ± 0.6
[Na?]U (mEq/l) 58.0 ± 23.2
[Cl-]U (mEq/l) 127.8 ± 68.5
[K?]U (mEq/l) 46.1 ± 17.4
[NH4
?]U (mEq/l) 16.0 ± 13.1
[AG]U (mEq/l) -23.6 ± 57.8
All values are expressed as mean ± standard deviation
PCO2 partial pressure of carbon dioxide, SID strong ion difference,
ATOT plasma concentration of non-carbonic weak acids, Alb albu-
min concentration, Phosph phosphate concentration, BE base
excess, pHa arterial pH, HCO3
- bicarbonate concentration, Na?
sodium concentration, Cl- chloride concentration, K? potassium
concentration, Ca2? calcium concentration, Lac- lactate concen-
tration, Osmolarity effective plasma osmolarity, [pH]U urinary pH,
[Na?]U urinary sodium concentration, [Cl
-]U urinary chloride
concentration, [K?]U urinary potassium concentration, [NH4
?]U
urinary ammonium concentration, [AG]U urinary anion gap
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effective plasma dilution at the end of the infusion period
(time 120 min), according to the infused crystalloid. The
mean hemoglobin and albumin-derived plasma dilution
coefficients were not significantly different (12.9 ± 9.1%
and 12.8 ± 7.6%, respectively) and did not differ sig-
nificantly among the crystalloids used. Of note, however,
the urinary output was significantly lower and fluid bal-
ance more positive after the infusion of normal saline,
compared to lactated Ringer’s and rehydrating III
infusion.
Plasma variables
Figure 1 shows the time course of the independent vari-
ables and the resulting pH as a function of the three
crystalloid solutions. As shown in panel A, PCO2 was
maintained constant throughout the experiments, while
[ATOT] (panel B) was equally diluted by the three solu-
tions. In contrast the time course of plasma [SID]
variations (panel C) was significantly different when
infusing solutions with different SIDs. These changes in
Fig. 1 Plasma variations in independent variables induced by the
infusion of crystalloid solutions at different [SID]s (a, b, c) and the
consequent variations in plasma pH (d). Grey triangles represent
variations induced by the infusion of normal saline. White squares
represent variations induced by the infusion of lactated Ringer’s
solution. Black dots represent variations induced by the infusion of
rehydrating III. All data are expressed as mean ± standard
deviation. [ATOT] represents the plasma concentration of non-
carbonic weak acids; [ATOT] was measured at baseline, at the end of
the infusion, and at time 240 and 360 min; [SID]pl represents the
plasma strong ion difference. *p \ 0.05: Compared to baseline
value of the same group. p \0.05: Compared to time 120 min of
the same group; p \ 0.05: Rehydrating III or lactated Ringer’s
compared to normal saline. §p \0.05 Rehydrating III compared to
lactated Ringer’s. See text for additional explanations
Table 3 Dilution variables at time 120
Rehydrating III (RIII) Lactated Ringer’s (LR) Normal saline (NS)
Infused fluid (ml) 2,213 ± 329 2,213 ± 329 2,213 ± 329
Urinary output (ml) 907 ± 254 754 ± 190 644 ± 251*
Fluid balance (ml) 1,306 ± 452 1,459 ± 333 1,569 ± 347*
Hb-derived plasma dilution (%) 12.20 ± 9.47 15.53 ± 6.10 10.92 ± 11.06
Albumin-derived plasma dilution (%) 11.00 ± 7.67 14.66 ± 5.27 12.61 ± 9.49
The table summarizes dilution parameters at the end of the infusion (120 min). Fluid balance was defined as infused fluid minus urinary
output. See the Online Data Supplement for the Hb- and albumin-derived dilution explanation
* p \ 0.05 compared to rehydrating III
689
Table 4 Variations in plasma acid-base variables, electrolytes, and osmolarity
Time (min) 0 30 60 90 120 240 360
Rehydrating III
d[HCO3
-] (mmol/l) 0.00 ± 0.00 0.73 ± 1.25 1.19 ± 1.20 1.75 ± 1.67 3.23 ± 1.71 2.51 ± 2.43 2.01 ± 2.30
PTIME ** *** *** *** ***

PINF
 §  §  §§§  §§§  § 
dBE (mmol/l) 0.00 ± 0.00 0.84 ± 0.99 1.60 ± 1.27 2.13 ± 1.64 3.28 ± 1.56 2.94 ± 2.52 2.46 ± 2.28
PTIME *** *** *** *** ***
PINF
§  §§§  §§§  §§§ § 
d[Na?] (mEq/l) 0.00 ± 0.00 0.67 ± 1.07 1.33 ± 1.72 1.83 ± 1.75 1.92 ± 2.11 0.83 ± 2.59 0.25 ± 1.66
PTIME ** *** ***

PINF
     
d[Cl-] (mEq/l) 0.00 ± 0.00 -0.42 ± 2.28 -0.25 ± 2.45 0.08 ± 2.78 -1.08 ± 2.61 -1.58 ± 4.44 -1.50 ± 3.12
PTIME
PINF
  §  §§   
d[K?] (mEq/l) 0.00 ± 0.00 0.04 ± 0.14 0.03 ± 0.23 -0.04 ± 0.28 -0.05 ± 0.37 -0.20 ± 0.36 -0.23 ± 0.56
PTIME
PINF
    §§ §§
d[Lactate-] (mEq/l) 0.00 ± 0.00 0.00 ± 0.12 0.03 ± 0.16 0.01 ± 0.15 0.07 ± 0.12 0.02 ± 0.20 -0.05 ± 0.21
PTIME
PINF
 §§§  §§§  §§§  §§§  §
dOsm (mOsm/l) 0.00 ± 0.00 1.19 ± 1.99 2.49 ± 3.12 3.43 ± 3.14 3.65 ± 3.91 1.38 ± 4.71 0.34 ± 3.06
PTIME *** *** ***
 
PINF
     
Lactated Ringer’s
d[HCO3
-] (mmol/l) 0.00 ± 0.00 -0.86 ± 1.51 -0.83 ± 2.00 -0.69 ± 1.01 0.64 ± 1.11 1.07 ± 1.35 1.52 ± 2.54
PTIME **
PINF
    
dBE (mmol/l) 0.00 ± 0.00 -0.60 ± 1.10 -0.60 ± 1.85 -0.41 ± 1.04 0.62 ± 1.16 1.14 ± 1.55 1.44 ± 2.10
PTIME * **
PINF.
     
d[Na?] (mEq/l) 0.00 ± 0.00 0.33 ± 1.16 1.00 ± 2.09 1.17 ± 1.80 1.08 ± 1.78 0.00 ± 2.30 -0.82 ± 2.36
PTIME * * *

PINF
     
d[Cl-] (mEq/l) 0.00 ± 0.00 0.92 ± 2.47 2.00 ± 4.22 2.50 ± 2.54 0.67 ± 2.35 -0.17 ± 2.59 -1.73 ± 3.80
PTIME * ***

PINF
     
d[K?] (mEq/l) 0.00 ± 0.00 -0.12 ± 0.27 -0.13 ± 0.42 -0.11 ± 0.32 0.04 ± 0.25 0.25 ± 0.27 0.27 ± 0.41
PTIME *
PINF
    
d[Lactate-] (mEq/l) 0.00 ± 0.00 0.68 ± 0.22 0.74 ± 0.22 0.79 ± 0.31 0.68 ± 0.41 -0.08 ± 0.11 -0.06 ± 0.13
PTIME *** *** *** ***
***  * 
PINF
   
dOsm (mOsm/l) 0.00 ± 0.00 0.35 ± 2.17 1.71 ± 3.71 2.20 ± 3.45 2.35 ± 3.44 -0.04 ± 4.52 -1.86 ± 4.58
PTIME ** *** ***

PINF
     
Normal saline
d[HCO3
-] (mmol/l) 0.00 ± 0.00 -1.83 ± 1.20 -3.06 ± 1.20 -3.44 ± 1.60 -3.49 ± 1.61 -2.68 ± 1.29 -2.25 ± 1.83
PTIME *** *** *** *** *** ***

PINF
dBE (mmol/l) 0.00 ± 0.00 -2.09 ± 0.93 -3.48 ± 0.99 -3.93 ± 1.36 -4.20 ± 1.30 -3.19 ± 1.29 -2.88 ± 1.30
PTIME *** *** *** *** *** ***

PINF.
d[Na?] (mEq/l) 0.00 ± 0.00 2.17 ± 0.84 3.25 ± 1.06 4.17 ± 1.59 4.33 ± 1.92 2.92 ± 1.24 2.08 ± 2.19
PTIME *** *** *** *** *** ***

PINF
d[Cl-] (mEq/l) 0.00 ± 0.00 3.75 ± 1.77 6.67 ± 1.37 8.50 ± 3.12 8.08 ± 2.61 5.75 ± 2.22 4.58 ± 3.18
PTIME *** *** *** *** ***
 *** 
PINF
d[K?] (mEq/l) 0.00 ± 0.00 -0.43 ± 0.13 -0.54 ± 0.17 -0.48 ± 0.19 -0.45 ± 0.34 -0.13 ± 0.30 -0.02 ± 0.28
PTIME *** *** *** ***
 
PINF
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independent variables ([SID] and [ATOT]) induced the
variations in pH represented in panel D. As shown, while
the infusion of normal saline and rehydrating III caused
significant variations in pH (reduction and increase,
respectively), no variations were observed during the
infusion of lactated Ringer’s solution. Of note, the dif-
ference between baseline [HCO3
-] and [SID]inf expressed
in mEq/l was ?26.4 ± 2.5 for rehydrating III, -29 ± 2.7
for normal saline, and ?1.05 ± 2.35 for lactated Ringer’s
solution.
Plasma electrolytes and osmolarity
The time course of the individual electrolytes as well as of
osmolarity variations is reported in Table 4. As shown,
compared to normal saline, rehydrating III and lactated
Ringer’s differed in the time course of [Na?] (lower
increase), [Cl-] (lower increase), [K?] (significantly
decreased in normal saline), and lactate. Of note, the
increase in effective osmolarity was remarkably greater
with normal saline compared to the other two solutions.
Urinary output
As shown in Table 3, urinary output at the end of dilution
significantly differed among the solutions, being signifi-
cantly lower with normal saline. However, after the wash-
out period (4 h), the urinary volume was similar among
the three groups (1,366 ± 288 ml for rehydrating III,
1,336 ± 316 ml for lactated Ringer’s, and 1,263 ±
265 ml for normal saline).
In Fig. 2a we report the urinary pH changes as a
function of arterial pH changes recorded at each infusion
time and for each crystalloid solution. As shown, the
urinary pH variations roughly paralleled the arterial pH
variations, suggesting that the kidney reacted to the
Table 4 continued
Time (min) 0 30 60 90 120 240 360
d[Lactate-] (mEq/l) 0.00 ± 0.00 -0.12 ± 0.07 -0.19 ± 0.08 -0.20 ± 0.13 -0.20 ± 0.14 -0.17 ± 0.14 -0.14 ± 0.22
PTIME *** *** *** *** *** ***
PINF
dOsm (mOsm/l) 0.00 ± 0.00 3.81 ± 1.51 6.10 ± 1.81 7.81 ± 2.73 8.29 ± 3.54 5.48 ± 2.54 3.69 ± 4.60
PTIME *** *** *** *** *** ***

PINF
The table summarizes variations in plasma acid-base variables,
electrolytes, and osmolarity induced by the infusion of the crys-
talloid solutions. All data are expressed as mean ± standard
deviation
d[HCO3
-] variations in bicarbonate concentration, dBE variations
in base excess, d[Na?] variations in sodium concentration,
d[Cl-] variations in chloride concentration, d[K?] variations in
potassium concentration, d[Lactate-] variations in lactate con-
centration, dOsm variations in effective osmolarity
* p \ 0.05 versus baseline, ** p \ 0.01 versus baseline,
*** p \ 0.001 versus baseline,  p \ 0.05 versus time 120,
 p \ 0.01 versus time 120,  p \ 0.001 versus time 120,
 p \ 0.05 versus normal saline,  p \ 0.01 versus normal saline,
 p \ 0.001 versus normal saline, § p \ 0.05 versus lactated
Ringer’s, §§ p \ 0.01 versus lactated Ringer’s, §§§ p \ 0.001 versus
lactated Ringer’s. PTIME defines statistics over time, i.e., compared
to baseline value or to time 120. PINF defines statistics among
different types of crystalloids
Fig. 2 Figure represents, at each experimental point during the
infusion, the relationship between the urinary pH variations and the
arterial pH variations (panel A, intercept = 0.24, slope = 7.99,
r2 = 0.39, p \ 0.0001), and the relationship between urinary pH
variations and the urinary anion gap (panel B, intercept = 0.11,
slope = 9.29e–3, r2 = 0.41, p \ 0.0001) during the infusion of
different crystalloid solutions. Grey triangles represent variations
induced by the infusion of normal saline. White squares represent
variations induced by the infusion of lactated Ringer’s. Black dots
represent variations induced by the infusion of rehydrating III. Grey
solid lines represent linear regressions. See text for additional
explanations
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acid-base plasma perturbations by trying to minimize
them. This was likely obtained by readjusting the urinary
[SID], one of the determinants of urinary pH. Actually, as
shown in Fig. 2b, the changes in the urinary anion gap
([Na?]U ? [K
?]U – [Cl
-]U), a surrogate for urinary
[SID], were more negative during normal saline infusion,
unchanged during lactated Ringer’s infusion, and
increased during rehydrating III infusion.
Pooling together all the experimental points, we found
that the small variations in plasma [SID] were weakly but
significantly correlated with the larger variations of the
urinary anion gap (r2 = 0.07, p = 0.0002), which in turn
were significantly associated both with [Na?]U (r
2 = 0.22,
p \ 0.0001) and [Cl-]U (r
2 = 0.17, p \ 0.0001) changes
(see Figures 2, 3, and 4 in the Online Data Supplement).
In contrast, [K?]U changes were unrelated to urinary
anion gap changes, but were directly related to the
potassium loaded during the infusions (see Figures 5, 6, 7
and Table 1 in the Online Data Supplement).
Discussion
The findings in this study are consistent with the
hypothesis that in intact healthy animals at constant PCO2
the plasma pH can be predictably increased, decreased, or
maintained unchanged, according to the difference
between the baseline plasma [HCO3
-] and the strong ion
difference of the crystalloid solution infused. The theo-
retical background has been published previously [7] and
is summarized in the Online Data Supplement. In vitro
experiments with human plasma are consistent with the
rules identified in theory, and, in the present study, we
found that an intact animal behaves as the simple plasma
model.
In fact, in the current work, three different solutions
with [SID]inf greater than, similar to, or lower than the
baseline plasma [HCO3
-] were infused in each pig.
Actually, the baseline [HCO3
-] was around 29 mEq/l.
When diluting with lactated Ringer’s whose [SID] was
similar to the baseline [HCO3
-] ([SID]inf = 28.3 mEq/l
and [HCO3
-] = 29.35 ± 2.35 mmol/l), no significant
changes in pH were observed. In contrast, dilution with
the other two solutions having [SID]inf greater (rehy-
drating III, [SID]inf = 55 mEq/l) or smaller (normal
saline, SIDinf = 0 mEq/l) than baseline [HCO3
-] deter-
mined a significant increase and reduction in pH,
respectively, as observed in vitro.
The plasma dilution we achieved, according to the
reduction of the albumin and hemoglobin concentration
averaged 12%, a value that is consistent with the amount
of fluid retained during the infusion period. In this study
we did not measure or estimate the dilution of the dif-
ferent compartments, such as the interstititium and
cellular space. However, the fact that the recorded chan-
ges in plasma pH were consistent with the ones observed
during the dilution of isolated plasma suggests that also in
vivo (regardless of the movements among the intravas-
cular, interstitial, and intracellular space), the general rule
found in vitro may be true, i.e., plasma changes during
crystalloid infusion depend upon the difference between
infused [SID] and baseline [HCO3
-]. Our findings imply
therefore that the body can be considered as a ‘‘black
box’’ where, whatever the exchanges among plasma,
interstitial fluid and cells are, the acid-base status can be
easily predicted for any given input and output. While
input conditions are easily computed (the kind of solution
used and rate of delivery), the output has to be calculated
from the urine volume and its electrolyte composition, at
least of the electrolytes that are more relevant in deter-
mining the plasma [SID].
In this study we found that the response of the kidney
to a given crystalloid solution is, in general, to preserve
homeostasis. As far as the acid-base equilibrium is con-
cerned, the kidney reacts by decreasing the urinary [SID],
as inferred from the urinary anion gap, when infusing a
solution causing acidosis and increasing it when infusing
a solution causing alkalosis. This is a normal kidney
‘‘compensatory’’ response to plasma acid-base alterations
[16, 17].
However, beyond the [SID] differences, the infused
solution presented several other differences that could be
relevant in determining urine volume and its composition,
such as differences in osmolarity, potassium, and chloride
load. While the volume receptors were likely equally
stimulated by an identical volume load, the osmo-recep-
tors were probably differently activated by the three
solutions. In fact, after metabolism of the organic ions,
lactated Ringer’s and rehydrating III had an osmolarity
that was about 50 mOsm/l lower than that of normal
saline. The fact that lactate was nearly fully metabolized
during lactated Ringer’s infusion was documented by
plasma lactate variations lower than 1 mmol/l (see
Table 4). Therefore, the lower osmolarity of lactated
Ringer’s and rehydrating III via ADH suppression could
have contributed to the greater urine volume caused by
these infusions compared to the infusion of normal saline.
Another possible factor influencing the urine volume and
the electrolyte composition is the potassium load. Hypo-
kalemia can cause a downregulation of aldosterone, with
potassium-sparing effects and an increase of sodium plus
water in the urine, whereas hyperkalemia can produce the
opposite effects. Actually, in our experiments, we found
that during normal saline infusion the plasma level of
potassium was significantly reduced as well as its urinary
concentration. In contrast, the infusion of lactated Ring-
er’s and rehydrating III was associated with a significant
increase in potassium excretion in proportion to the
potassium load. Finally, the higher chloride concentration
present in normal saline, per se, may have led to
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variations in glomerular filtration rates/renal arteriolar
diameters [18, 19] with a consequent decrease in urinary
volume. In summary, different mechanisms are likely to
operate (sometimes in opposite directions) during the
infusion, and all of them may have contributed to the
urine pattern we recorded in these experiments.
We conclude that in healthy pigs with normal kidney
function, the acid-base response to the infusion of solu-
tions with different [SID]s is highly predictable and that
the kidney response is specific for each solution, acting to
restore the baseline conditions. If these findings could be
applied to human beings, the response to large volume
replacement of modifying plasma pH could be predicted.
Although these experiments were conducted in healthy
animals, the physicochemical basis of pH changes during
crystalloid infusion should be the same in patients. It is
however reasonable that the effects of crystalloid infu-
sions on acid-base concentrations may be amplified in
some conditions that are typical for critical illness, e.g.,
hypovolemia and renal failure [20–22]. Indeed, the
physiological triggers for water and sodium elimination
are not immediately activated in the first case, and in the
case of renal failure, the kidney response to volume and
electrolyte load is inadequate for the maintenance of
homeostasis.
The call for a reasoned and rational use of crystalloid
solutions is therefore straightforward, especially for crit-
ically ill patients.
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